Legal & General Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $309M | Sell |
934,881
-26,615
| -3% | -$9.06M | 0.07% | 267 |
|
|
2025
Q4 | $382M | Buy |
961,496
+73,716
| +8% | +$32.6M | 0.08% | 222 |
|
|
2025
Q3 | $405M | Buy |
887,780
+15,009
| +2% | +$6.11M | 0.09% | 211 |
|
|
2025
Q2 | $285M | Sell |
872,771
-8,340
| -0.9% | -$2.31M | 0.07% | 278 |
|
|
2025
Q1 | $238M | Buy |
881,111
+52,194
| +6% | +$13.4M | 0.06% | 304 |
|
|
2024
Q4 | $195M | Buy |
828,917
+37,188
| +5% | +$9.78M | 0.05% | 354 |
|
|
2024
Q3 | $218M | Buy |
791,729
+29,810
| +4% | +$7.76M | 0.06% | 330 |
|
|
2024
Q2 | $185M | Buy |
761,919
+11,317
| +2% | +$1.79M | 0.05% | 344 |
|
|
2024
Q1 | $112M | Sell |
750,602
-7,902
| -1% | -$1.32M | 0.03% | 468 |
|
|
2023
Q4 | $145M | Sell |
758,504
-36,167
| -5% | -$6.16M | 0.05% | 398 |
|
|
2023
Q3 | $141M | Sell |
794,671
-3,718
| -0.5% | -$709K | 0.05% | 386 |
|
|
2023
Q2 | $152M | Buy |
798,389
+67,367
| +9% | +$13.4M | 0.05% | 387 |
|
|
2023
Q1 | $146M | Sell |
731,022
-1,333
| -0.2% | -$280K | 0.05% | 380 |
|
|
2022
Q4 | $174M | Sell |
732,355
-22,137
| -3% | -$4.72M | 0.07% | 335 |
|
|
2022
Q3 | $151M | Sell |
754,492
-24,456
| -3% | -$4.66M | 0.06% | 357 |
|
|
2022
Q2 | $114M | Buy |
778,948
+21,526
| +3% | +$3.05M | 0.04% | 451 |
|
|
2022
Q1 | $124M | Buy |
757,422
+77,852
| +11% | +$11.9M | 0.04% | 474 |
|
|
2021
Q4 | $115M | Buy |
679,570
+12,785
| +2% | +$2.38M | 0.03% | 491 |
|
|
2021
Q3 | $126M | Sell |
666,785
-16,625
| -2% | -$3.12M | 0.04% | 469 |
|
|
2021
Q2 | $116M | Buy |
683,410
+36,972
| +6% | +$5.41M | 0.04% | 489 |
|
|
2021
Q1 | $91.3M | Buy |
646,438
+1,066
| +0.2% | +$160K | 0.03% | 534 |
|
|
2020
Q4 | $83.9M | Buy |
645,372
+14,580
| +2% | +$1.95M | 0.03% | 529 |
|
|
2020
Q3 | $91.8M | Sell |
630,792
-2,284
| -0.4% | -$325K | 0.04% | 441 |
|
|
2020
Q2 | $93.8M | Buy |
633,076
+29,439
| +5% | +$3.97M | 0.05% | 419 |
|
|
2020
Q1 | $65.7M | Buy |
603,637
+29,567
| +5% | +$3.41M | 0.04% | 453 |
|
|
2019
Q4 | $66.1M | Buy |
574,070
+40,774
| +8% | +$4.07M | 0.03% | 535 |
|
|
2019
Q3 | $42.9M | Buy |
533,296
+32,349
| +6% | +$2.56M | 0.02% | 608 |
|
|
2019
Q2 | $36.3M | Buy |
500,947
+26,365
| +6% | +$2.02M | 0.02% | 647 |
|
|
2019
Q1 | $44.3M | Buy |
474,582
+107,682
| +29% | +$9.01M | 0.03% | 581 |
|
|
2018
Q4 | $26.8M | Buy |
366,900
+26,958
| +8% | +$2.07M | 0.02% | 620 |
|
|
2018
Q3 | $29.8M | Sell |
339,942
-569
| -0.2% | -$57.2K | 0.02% | 635 |
|
|
2018
Q2 | $33.5M | Sell |
340,511
-8,059
| -2% | -$799K | 0.03% | 602 |
|
|
2018
Q1 | $41.5M | Buy |
348,570
+242,098
| +227% | +$31.2M | 0.03% | 560 |
|
|
2017
Q4 | $13.5M | Buy |
106,472
+74,112
| +229% | +$9.31M | 0.01% | 744 |
|
|
2017
Q3 | $3.8M | Buy |
32,360
+4,477
| +16% | +$382K | ﹤0.01% | 1209 |
|
|
2017
Q2 | $2.22M | Buy |
27,883
+3,144
| +13% | +$201K | ﹤0.01% | 1474 |
|
|
2017
Q1 | $1.27M | Sell |
24,739
-222,628
| -90% | -$10.3M | ﹤0.01% | 1711 |
|
|
2016
Q4 | $9.26M | Sell |
247,367
-45,545
| -16% | -$1.91M | 0.01% | 736 |
|
|
2016
Q3 | $19.9M | Sell |
292,912
-4,030
| -1% | -$284K | 0.02% | 593 |
|
|
2016
Q2 | $16.5M | Buy |
296,942
+5,446
| +2% | +$343K | 0.02% | 607 |
|
|
2016
Q1 | $18.3M | Buy |
291,496
+2,229
| +0.8% | +$148K | 0.02% | 596 |
|
|
2015
Q4 | $27.2M | Buy |
289,267
+10,609
| +4% | +$984K | 0.03% | 533 |
|
|
2015
Q3 | $22.4M | Buy |
278,658
+252,952
| +984% | +$28.1M | 0.03% | 555 |
|
|
2015
Q2 | $3.08M | Buy |
25,706
+23,389
| +1,009% | +$2.8M | ﹤0.01% | 829 |
|
|
2015
Q1 | $242K | Buy |
+2,317
| New | +$235K | ﹤0.01% | 1593 |
|
Other funds holding ALNY
VPM
VCM
